AVITA Medical, Inc. (RCEL) Misses Q2 EPS by 13c

AVITA Medical, Inc. (NASDAQ: RCEL) reported Q2 EPS of ($0.38), $0.13 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $18.4 million versus the consensus estimate of $22.51 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.

You May Also Be Interested In

• Goldman Sachs Reiterates Conviction Buy Rating on Golar LNG Ltd. (GLNG)
• Goldman Sachs Downgrades Daihen Corp (6622:JP) to Neutral
• iHeartMedia (IHRT) PT Lowered to $5 at BofA Securities